Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Payables (2016 - 2019)

Fresenius Medical Care AG (FMS) has 11 years of Payables data on record, last reported at $2.1 billion in Q4 2019.

  • For Q4 2019, Payables fell 1.98% year-over-year to $2.1 billion; the TTM value through Dec 2019 reached $2.1 billion, down 1.98%, while the annual FY2019 figure was $2.1 billion, 1.98% down from the prior year.
  • Payables reached $2.1 billion in Q4 2019 per FMS's latest filing, down from $2.1 billion in the prior quarter.
  • Across five years, Payables topped out at $2.1 billion in Q4 2018 and bottomed at $627.8 million in Q4 2015.
  • Average Payables over 5 years is $1.5 billion, with a median of $1.6 billion recorded in 2017.
  • Peak YoY movement for Payables: decreased 11.05% in 2015, then soared 97.35% in 2016.
  • A 5-year view of Payables shows it stood at $627.8 million in 2015, then skyrocketed by 97.35% to $1.2 billion in 2016, then increased by 28.36% to $1.6 billion in 2017, then soared by 32.52% to $2.1 billion in 2018, then dropped by 1.98% to $2.1 billion in 2019.
  • Per Business Quant database, its latest 3 readings for Payables were $2.1 billion in Q4 2019, $2.1 billion in Q4 2018, and $1.6 billion in Q4 2017.